Site Map
Site Map of
http://www.researchandmarkets.com
-
Site Map
-
Pharmaceuticals and Healthcare
-
Pharmaceuticals 1
(
Latest Titles
)
Pharmaceuticals 2
Pharmaceuticals 3
Pharmaceuticals 4
-
Infectious Diseases
<< You are in This Category
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Advances in the Treatment of Serious Systemic Fungal Infections--An Update
static version
printer friendly
pdf version
Aminoglycoside Antibiotics: From Chemical Biology to Drug Discovery
static version
printer friendly
pdf version
Antibacterial Drug Licensing Opportunities: Analysis, Rating, and Ranking - A Worldwide Study
static version
printer friendly
pdf version
Antibacterial Market Survey: Analyses and Forecasts…Technology, Sales and Company Profiles
static version
printer friendly
pdf version
Antibacterial: Drug Licensing Opportunities, 2002
static version
printer friendly
pdf version
Antibiotic Resistance: Opinion Leader Forum, 2002
static version
printer friendly
pdf version
Antiviral Drug Licensing Opportunities: Analysis, Rating, and Ranking - A Worldwide Study
static version
printer friendly
pdf version
Antiviral Resistance: Innovation Reshaping Viral Treatment, 2001 Edition
static version
printer friendly
pdf version
Antivirals - A Broad Market Overview
static version
printer friendly
pdf version
Approved AIDS and AIDS-Related Drugs, 1987-2003
static version
printer friendly
pdf version
Autoimmune/Inflammatory Disease Drug Licensing Opportunities: Analysis, Rating and Ranking - A Worldwide Study
static version
printer friendly
pdf version
Autoimmune/Inflammatory Disease: Competitive Strategies - Competitive Analysis, Profiles, and Portfolio Strategies of the Top Autoimmune/Inflammatory Therapeutic Manufacturers in the US (2001 Edition)
static version
printer friendly
pdf version
Avian Influenza: The Threatening Pandemic
static version
printer friendly
pdf version
^ Top
B
Bacterial Infections: An Epidemiological Overview
static version
printer friendly
pdf version
Bacterial Infections: An Epidemiological Overview
static version
printer friendly
pdf version
^ Top
C
Chinese Markets for HIV Treatment Drugs
static version
printer friendly
pdf version
Commercial Insight: HIV - Change of Guard
static version
printer friendly
pdf version
Commercial Insight: HIV in the USA - Increasing Choice, Flexibility and Competition
static version
printer friendly
pdf version
^ Top
D
Disease & Therapy Review (DTR) Executive Market Summaries
static version
printer friendly
pdf version
Disease and Therapy Review: Hepatitis B
static version
printer friendly
pdf version
Disease and Therapy Review: Hepatitis C
static version
printer friendly
pdf version
Drugs and Vaccines in Development of Infectious Diseases, 2004
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Bacterial Infections
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Hepatitis - The Succession of New Generation Therapies
static version
printer friendly
pdf version
^ Top
F
Fierce Competition for a Shrinking HCV Market
static version
printer friendly
pdf version
^ Top
H
Hepatitis C virus (HCV) - Fierce Competition for a Shrinking HCV Market?
static version
printer friendly
pdf version
Hepatitis C virus (HCV) - Future HCV Drug Discovery Technologies
static version
printer friendly
pdf version
HIV Pricing Strategies in the US and UK
static version
printer friendly
pdf version
HIV Update 2002 (11) - November
static version
printer friendly
pdf version
HIV Update 2002 (12) - December
static version
printer friendly
pdf version
HIV Update 2003 (1) - January
static version
printer friendly
pdf version
HIV Update 2003 (2) - February
static version
printer friendly
pdf version
HIV Update 2003 (3) - March
static version
printer friendly
pdf version
Human Virology
static version
printer friendly
pdf version
^ Top
I
ICAAC 2007 Leadership Summit: Discussion among Nine Infectious Disease Specialists
static version
printer friendly
pdf version
Infections - AIDS HIV Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Bacterial Infections Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Ear Infections Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Fever Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Fungal Infections or Candidiasis Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Helminthic Infestations Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Hepatitis B Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Hepatitis C Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Herpes Simplex Virus Infection Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Influenza Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Malaria Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Pneumonia Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Staphylococcal Infections Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Tuberculosis Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Urinary Tract Infections Drug Pipeline Report
static version
printer friendly
pdf version
Infections - Viral Infections
static version
printer friendly
pdf version
Infections - Viral Infections Drug Pipeline Report
static version
printer friendly
pdf version
Infections AIDS HIV
static version
printer friendly
pdf version
Infections Bacterial Infections
static version
printer friendly
pdf version
Infections Ear Infections
static version
printer friendly
pdf version
Infections Fever
static version
printer friendly
pdf version
Infections Fungal Infections or Candidiasis
static version
printer friendly
pdf version
Infections Helminthic Infestations
static version
printer friendly
pdf version
Infections Hepatitis B
static version
printer friendly
pdf version
Infections Hepatitis C
static version
printer friendly
pdf version
Infections Herpes Simplex Virus Infection
static version
printer friendly
pdf version
Infections Influenza
static version
printer friendly
pdf version
Infections Malaria
static version
printer friendly
pdf version
Infections Pneumonia
static version
printer friendly
pdf version
Infections Staphylococcal Infections
static version
printer friendly
pdf version
Infections Tuberculosis
static version
printer friendly
pdf version
Infections Urinary Tract Infections
static version
printer friendly
pdf version
Interferon Current Market Dynamics & Future Outlook
static version
printer friendly
pdf version
^ Top
M
Market Dynamics 2001: Bacterial Infections
static version
printer friendly
pdf version
Market Dynamics 2001: Hepatitis B&C - The Succession of New Generation Therapies
static version
printer friendly
pdf version
Molecular Approaches Towards Hepatitis C virus (HCV) Therapy - The Complete Guide
static version
printer friendly
pdf version
^ Top
N
New Pegylated Interferons: Assessing the Impact of the New Longer Acting Interferons on the Hepatitis C Market
static version
printer friendly
pdf version
New Targets and Drug Discovery Platforms in Antifungal R&D
static version
printer friendly
pdf version
^ Top
O
Oxford Handbook of Genitourinary Medicine, HIV and AIDS, First Edition
static version
printer friendly
pdf version
^ Top
P
Partneringdesk Deals and alliances in infectious diseases
static version
printer friendly
pdf version
Partneringreview 2006: Biopharma Deal Making By Therapy Area - Infectious Diseases
static version
printer friendly
pdf version
Pharmaceuticals and Politics: Will Political Opinion Affect the Future of HPV Vaccines?
static version
printer friendly
pdf version
Pipeline Perspectives: Hepatitis B and C - Antivirals Challenge the Interferons?
static version
printer friendly
pdf version
Pipeline Perspectives: Hepatitis B and C - Antivirals Challenge the Interferons?
static version
printer friendly
pdf version
^ Top
R
Respiratory Syncytial Virus: Can Antivirals Make the Grade?
static version
printer friendly
pdf version
^ Top
S
Sexually Transmitted Infections - The Silent Menace
static version
printer friendly
pdf version
Stakeholder Insight: HIV Therapy Dynamics
static version
printer friendly
pdf version
Stakeholder Opinions: Biologics in Infectious Diseases - Well Defined Target Populations are Key to Commercial Success
static version
printer friendly
pdf version
Strategic Perspective 2001: The Hospital Antibacterial Market - Economic Constraints Drive Development of Niche Products
static version
printer friendly
pdf version
Strategic Perspectives 2001: Infectious Diseases in Emerging Markets - Creating a Strategy for Success
static version
printer friendly
pdf version
Strategic Perspectives 2001: The Antiviral Market - A Market For Expanding Indications
static version
printer friendly
pdf version
Strategic Perspectives 2001: Vaccines
static version
printer friendly
pdf version
Strategic Perspectives: Opportunistic Infections in HIV
static version
printer friendly
pdf version
Superficial Fungal Infections. Brand Awareness - the key to success?
static version
printer friendly
pdf version
Systemic Antifungal Infections - Impact of the Latestage Pipeline
static version
printer friendly
pdf version
^ Top
T
Target Product Profiles 2008: Physician Insights on Key Attributes - Community-Acquired Pneumonia
static version
printer friendly
pdf version
Target Product Profiles 2008: Physician Insights on Key Attributes - Hepatitis C Virus
static version
printer friendly
pdf version
The Chinese hepatitis B market - Overcoming hurdles to investment
static version
printer friendly
pdf version
The Global Antivirals Market: R&D Pipelines, Market Analysis and Competitive Landscape
static version
printer friendly
pdf version
The Infectious Disease Market in 2001: A Year in Review
static version
printer friendly
pdf version
The Next Generation Antifungals: Triazoles vs. Peptides
static version
printer friendly
pdf version
Therapeutic Monoclonal Antibodies Marketed and In-Development Products
static version
printer friendly
pdf version
Therapeutic Polyclonal Antibody Products Marketed and In-Development Products
static version
printer friendly
pdf version
Travelers’ Infectious Diseases: Exploiting the World of Travel Vaccines?
static version
printer friendly
pdf version
Treatment Algorithms 2002: Hepatitis B and C
static version
printer friendly
pdf version
Tuberculosis: Trends, Challenges, and Opportunities in a Resurging Market
static version
printer friendly
pdf version
^ Top
U
U.S. Infectious Disease Vaccine Pipeline
static version
printer friendly
pdf version
U.S. Non-Infectious Disease Vaccine Pipeline
static version
printer friendly
pdf version
All rights reserved. © copyright 2006 Research and Markets
Terms and conditions
Privacy Policy